Skip to main content
. 2018 Nov 28;21(3):601–610. doi: 10.1111/dom.13562

Figure 2.

Figure 2

Pharmacodynamic profiles. Mean plasma glucose concentration profiles and SEM at euglycaemia (A) and at hypoglycaemia (B) after single subcutaneous doses of dasiglucagon and commercial glucagon (Eli Lilly)